123 related articles for article (PubMed ID: 37939638)
21. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire.
Ammann S; Lehmberg K; Zur Stadt U; Janka G; Rensing-Ehl A; Klemann C; Heeg M; Bode S; Fuchs I; Ehl S;
Eur J Immunol; 2017 Feb; 47(2):364-373. PubMed ID: 27925643
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases.
Imashuku S; Hibi S; Sako M; Ishii T; Kohdera U; Kitazawa K; Ooe K; Naya M; Sawada H; Kawakami T
J Pediatr Hematol Oncol; 1998; 20(3):207-14. PubMed ID: 9628431
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.
Wada T; Sakakibara Y; Nishimura R; Toma T; Ueno Y; Horita S; Tanaka T; Nishi M; Kato K; Yasumi T; Ohara O; Yachie A
Hum Immunol; 2013 Dec; 74(12):1579-85. PubMed ID: 24051121
[TBL] [Abstract][Full Text] [Related]
24. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
Benito JM; Zabay JM; Gil J; Bermejo M; Escudero A; Sánchez E; Fernández-Cruz E
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):128-35. PubMed ID: 9052721
[TBL] [Abstract][Full Text] [Related]
25. The inhibitory receptors on NK cells and CTLs are upregulated in adult and adolescent patients with secondary hemophagocytic lymphohistiocytosis.
Gao Z; Wang Y; Wang J; Zhang J; Wang Z
Clin Immunol; 2019 May; 202():18-28. PubMed ID: 30914280
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
[TBL] [Abstract][Full Text] [Related]
27. CD38
Mastrolia MV; Boscia S; Galli L; Lodi L; Pisano L; Maccora I; Ricci S; Pagnini I; Marrani E; Azzari C; Simonini G
Eur J Pediatr; 2023 Mar; 182(3):1429-1432. PubMed ID: 36631689
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
[TBL] [Abstract][Full Text] [Related]
29. EBV-HLH children with reductions in CD4+ T cells and excessive activation of CD8+ T cells.
Yang C; Zhu X; Zhang T; Ye Q
Pediatr Res; 2017 Dec; 82(6):952-957. PubMed ID: 28738028
[TBL] [Abstract][Full Text] [Related]
30. [The Value of T Cell subsets and Cytokine Levels Changes in the Clinical Diagnosis, Treatment and Prognosis Evaluation of Multiple Myeloma].
Yan ZM; Liu YQ; Huang ZF; Liang Y; Lin J; Shen JZ; Chen XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1791-1796. PubMed ID: 36476905
[TBL] [Abstract][Full Text] [Related]
31. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of High-Risk Clinical Factors of Early Death in Secondary Hemophagocytic Lymphohistiocytosis].
Zhu JL; Wu F; Hu LH; Zhai ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1866-1871. PubMed ID: 38071074
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells.
Lehmann D; Karussis D; Mizrachi-Koll R; Linde AS; Abramsky O
Clin Immunol Immunopathol; 1997 Nov; 85(2):202-9. PubMed ID: 9344704
[TBL] [Abstract][Full Text] [Related]
34. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
[TBL] [Abstract][Full Text] [Related]
35. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of hemophagocytic lymphohistiocytosis: a retrospective study comparing adult macrophage activation syndrome to malignancy-associated hemophagocytic lymphohistiocytosis.
Good SD; Wade SD; Kyttaris VC
Rheumatol Int; 2022 Jul; 42(7):1247-1255. PubMed ID: 35015099
[TBL] [Abstract][Full Text] [Related]
37. Selective loss of peripheral blood CD45RO+ T lymphocytes correlates with increased levels of serum cytokines and endothelial cell-derived soluble cell adhesion molecules in patients with chronic idiopathic neutropenia of adults.
Papadaki HA; Eliopoulos GD
Ann Hematol; 1998 Oct; 77(4):153-9. PubMed ID: 9829846
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
39. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
[TBL] [Abstract][Full Text] [Related]
40. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs.
Dau PC; Callahan JP
Clin Immunol Immunopathol; 1994 Feb; 70(2):159-65. PubMed ID: 8299231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
